Increasing demand and the need for shorter development times are convincing vaccine manufacturers to switch from traditional egg-based production to advanced mammalian cell-culture fermentation.Efficient fermentation requires careful monitoring and control of analytical parameters such as pH and dissolved oxygen.

In a new white paper'From Egg to Bioreactor',Mettler Toledo explains the change in vaccine production and how recent developments in analytical sensor technology lead to improved process reliability in cell culturing.